Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 137 B, Issue 1, 2005, Pages 40-44

  Bruce, Kenneth R ^a   Steiger, Howard ^a   Joober, Ridha ^a   Kin, N M K Ng Ying ^a   Israel, Mimi ^a   Young, Simon N ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

1438G A promoter polymorphism; 5 HT2A receptor; Bulimia nervosa

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; GENOMIC DNA; PROLACTIN; SEROTONIN; SEROTONIN 2A RECEPTOR;

ADULT; ALLELE; ARTICLE; BULIMIA; CANADA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMPULSIVENESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROMOTER REGION; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BODY MASS INDEX; BULIMIA NERVOSA; FEMALE; GENOTYPE; HUMANS; IMPULSIVE BEHAVIOR; MULTIVARIATE ANALYSIS; PIPERAZINES; POLYMORPHISM, GENETIC; PROLACTIN; PROMOTER REGIONS (GENETICS); RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SEROTONIN AGONISTS;

EID: 23044488229     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30205     Document Type: Article

References (37)

1. American Psychiatric Association. 1994. Diagnositic and statistical manual of mental disorders. 4th edn. Washington DC.
2. Brewerton TD. 1989. Seasonal variation of serotonin function in humans: Research and clinical implications. Ann Clin Psychiatry 1: 153-164.
3. Brewerton TD, Jimerson DC. 1996. Studies of serotonin function in anorexia nervosa. Psychiatry Res 62:31-42.
4. Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC. 1992. Neuroendocrine responses to m- chlorophenylpiperazine and L-tryptophan in bulimia. Arch Gen Psychiatry 49:852-861.
5. Bruce KR, Steiger H, Koerner NM, Israel M, Young SN. 2004. Bulimia nervosa with co-morbid avoidant personality disorder: behavioural characteristics and serotonergic function. Psychol Med 34:113-124.
6. Bucholz KK, Robins LN, Shayka JJ, Przybeck TR, Heltzer JE, Goldring E, Klein MH, Greist JH, Erdman HP, Skare SS. 1991. Performance of two forms of a computer psychiatric screening interview; Version 1 of the DISSI. J Psychiatric Res 25:117-129.
7. Cowen PJ, Clifford EM, Walsh AE, Williams C, Fairburn CG. 1996. Moderate dieting causes 5-HT2C receptor supersensitivity. Psychol Med 26:1155-1159.
8. Enoch MA, Kaye WH, Rotondo A, Greenberg BD, Murphy DL, Goldman D. 1998. 5-HT2A promotor polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 351:1785-1786.
9. Fairburn CG, Cooper P. 1993. The eating disorders examination. In: Fairburn C, Wilson G, edtiors. Binge eating: Nature, assessment and treatment, 12th edn. New York: Guilford Press, pp 317-360.
10. Fuentes JA, Lauzurica N, Hurtado A, Escarti A, Barrios V, Morande G, Soriano J, Jauregui I, Gonzalez-Valdemoro MI, Garcia-Camba E. 2004. Analysis of the -1438 G/A polymorphism of the 5-HT2A serotonin receptor gene in bulimia nervosa patients with or without a history of anorexia nervosa. Psychiatric Genet 14:107-109.
11. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. 1982. The eating attitudes test: Psychometric features and clinical correlates. Psychol Med 12:871-878.
12. Jimerson DC, Wolfe BE, Metzger ED, Finkelstein DM, Cooper TB, Levine JM. 1997. Decreased serotonin function in bulimia nervosa. Arch Gen Psychiatry 54:529-534.
13. Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ. 1998. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 55:927-935.
14. Kaye WH, Frank GK, Meltzer CC, Price JC, McConaha CW, Crossan PJ, Klump KL, Rhodes L. 2001. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158:1152-1155.
15. Kipman A, Bruins-Slot L, Boni C, Hanoun N, Ades J, Blot P, Hamon M, Mouren-Simeoni M, Gorwood P. 2002. 5-HT(2A) gene promoter polymorphism as a modifying rather than a vulnerability factor in anorexia nervosa. Eur Psychiatry 17:227-229.
16. Lepage D, Jolicoeur FB, Ggheysen F, Caillard V, Diener JMm, Castagnet F, Lomazzi H, Raffrey G, Zarafian E. 1996. Diagnostic interview schedule: Validation d'une version française informatisée. [Diagnostic interview schedule: Validation of a computerized French version]. Annales de Psychiatrie 11:5-13.
17. Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM. 1997. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa. Arch Gen Psychiatry 54:521-527.
18. Monteleone P, Brambilla F, Bortolotti F, Maj M. 2000. Serotonergic dysfunction across the eating disorders: Relationship to eating behaviour, purging behaviour, nutritional status and general psychopathology. Psychol Med 30:1099-1110.
19. Moss HB, Yao JK, Panzak GL. 1990. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 28:325-338.
20. Mueller EA, Murphy DL, Sunderland T. 1985. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol Metabol 61:1179-1184.
21. Nacmias B, Ricca V, Tedde A, Mezzani B, Rotella CM, Sorbi S. 1999. 5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa. Neurosci Letters 277:134-136.
22. Nishiguchi N, Matsushita S, Suzuki K, Murayama M, Shirakawa O, Higuchi S. 2001. Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients. Biol Psychiatry 50:123-128.
23. Paris J, Zweig-Frank H, Kin NM, Schwartz G, Steiger H, Nair NP. 2004. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res 121:239-252.
24. Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. 2004. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry 56:406-410.
25. Patton JH, Stanford MS, Barrat E. 1995. Factor structure of the barrat impulsiveness scale. J Clin Psychol 51:609-774.
26. Ricca V, Nacmias B, Cellini E, Di Bernardo M, Rotella CM, Sorbi S. 2002. 5-HT2A receptor gene polymorphism and eating disorders. Neurosci Letters 323:105-108.
27. Ricca V, Nacmias B, Boldrini M, Cellini E, di Bernardo M, Ravaldi C, Tedde A, Bagnoli S, Placidi GF, Rotella CM, Sorbi S. 2004. Psychopathological traits and 5-HT2A receptor promoter polymorphism (-1438 G/A) in patients suffering from Anorexia Nervosa and Bulimia Nervosa. Neurosci Letters 365:92-96.
28. Shimizu M, Kanazawa K, Matsuda Y, Takai E, Iwai C, Miyamoto Y, Hashimoto M, Akita H, Yokoyama M. 2003. Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation. Thromb Res 112:137-142.
29. Steiger H, Young SN, Kin NM, Koerner N, Israel M, Lageix P, Paris J. 2001a. Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 31:85-95.
30. Steiger H, Koerner N, Engelberg MJ, Israel M, Ng Ying Kin NM, Young SN. 2001b. Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Res 103:15-26.
31. Steiger H, Gauvin L, Israel M, Koerner N, Ng Ying Kin NM, Paris J, Young SN. 2001c. Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa. Arch Gen Psychiatry 58:837-843.
32. Steiger H, Israel M, Gauvin L, Ng Ying Kin NM, Young SN. 2003. Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa. Psychiatry Res 120:219-229.
33. Steiger H, Joober R, Israël M, Young SN, Ng Ying Kin NMK, Gauvin L, Bruce KR, Joncas J, Torkaman-Zehi A. 2005. The 5HTTLPR polymorphism, psychopathological symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord 37:57-60.
34. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW. 2004. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: Interactions with global 5-HT depletion. Psychopharmacol 176:376-385.
35. Wolfe BE, Metzger ED, Levine JM, Finkelstein DM, Cooper TB, Jimerson DC. 2000. Serotonin function following remission from bulimia nervosa. Neuropsychopharmacol 22:257-263.
36. Yatham LN, Steiner M. 1993. Neuroendocrine probes of serotonergic functions: A critical review. Life Sci 53, 447-463.
37. Ziegler A, Hebebrand J, Gorg T, Rosenkranz K, Fichter MM, Herpertz-Dahlmann B. 1999. Further lack of association between 5-HT2A gene promotor polymorphisms and susceptibility to eating disorders and a meta-analysis pertaining to anorexia nervosa. Mol Psychiatry 4: 410-412.